These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16391819)

  • 41. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence.
    Barnes N; Haywood P; Flint P; Knox WF; Bundred NJ
    Br J Cancer; 2006 Jan; 94(2):253-8. PubMed ID: 16421596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.
    Teramoto S; Arihiro K; Koseki M; Kataoka T; Asahara T; Ohdan H
    Hiroshima J Med Sci; 2008 Jun; 57(2):73-8. PubMed ID: 18717190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparanase promotes angiogenesis through Cox-2 and HIF1alpha.
    Naomoto Y; Gunduz M; Takaoka M; Okawa T; Gunduz E; Nobuhisa T; Kobayashi M; Shirakawa Y; Yamatsuji T; Sonoda R; Matsuoka J; Tanaka N
    Med Hypotheses; 2007; 68(1):162-5. PubMed ID: 16890383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29].
    Liu Y; Ding YQ; Xin XY; Han LF; Liang L
    Ai Zheng; 2005 Dec; 24(12):1427-30. PubMed ID: 16351786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparanase expression in endometrial cancer: analysis of immunohistochemistry.
    Inamine M; Nagai Y; Hirakawa M; Mekaru K; Yagi C; Masamoto H; Aoki Y
    J Obstet Gynaecol; 2008 Aug; 28(6):634-7. PubMed ID: 19003663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression characteristics of heparanase in colon carcinoma and its close relationship with cyclooxygenase-2 and angiogenesis.
    Wu BW; Li DF; Ke ZF; Ma D; Li YJ; Gang D; Zheng ZG; Zhang KJ; Zhang YH
    Hepatogastroenterology; 2010; 57(104):1510-4. PubMed ID: 21443112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
    Wang XB; Yang QX; Pei XJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification.
    Perrone G; Zagami M; Santini D; Vincenzi B; Gullotta G; Morini S; Battista C; Guerriero G; Altomare V; Tonini G; Rabitti C
    Histopathology; 2007 Jul; 51(1):33-9. PubMed ID: 17542993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
    Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer.
    Vleugel MM; Greijer AE; Bos R; van der Wall E; van Diest PJ
    Hum Pathol; 2006 Jun; 37(6):668-74. PubMed ID: 16733206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Function of heparanase in prostate tumorigenesis: potential for therapy.
    Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
    Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cox-2 expression on tissue microarray of breast cancer.
    Park K; Han S; Shin E; Kim HJ; Kim JY
    Eur J Surg Oncol; 2006 Dec; 32(10):1093-6. PubMed ID: 16797158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparanase procoagulant effects and inhibition by heparins.
    Nadir Y; Brenner B
    Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
    Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.